InvestorsHub Logo
Followers 98
Posts 4025
Boards Moderated 0
Alias Born 10/05/2008

Re: raja48185 post# 79470

Saturday, 08/14/2021 11:34:11 PM

Saturday, August 14, 2021 11:34:11 PM

Post# of 118390
Everything Koos has done points to RGBP being set up for a buyout, nothing else makes sense especially going into clinical trials. We know the IP is very valuable and a large pharma will easily pay $1 billion+ to add it to their portfolio.